Peptide Storage and Cold Chain Handling Guide

Why Storage Conditions Matter

Peptides are chains of amino acids linked by peptide bonds. While this linkage is chemically robust under appropriate conditions, elevated temperature, moisture, light, and oxidative exposure can all degrade peptide integrity through distinct mechanisms:

• Thermal degradation: Heat accelerates hydrolysis of peptide bonds and promotes aggregation, particularly in larger peptides and those with significant hydrophobic regions. The rate of degradation approximately doubles with every 10°C increase in temperature — a relationship described by the Arrhenius equation and fundamental to pharmaceutical stability science.
• Hydrolysis: Water is the primary reactant in peptide bond cleavage. Even residual moisture in a lyophilisate can catalyse degradation over time. This is why lyophilisation is the preferred preservation method — removing water substantially slows hydrolytic degradation.
• Oxidation: Amino acid side chains susceptible to oxidation include methionine (conversion to methionine sulfoxide), tryptophan, tyrosine, and cysteine residues involved in disulphide bonds. Oxidation alters the chemical structure and may change the biological activity of the peptide in research assays.
• Photo-degradation: UV and visible light drive photo-oxidation of aromatic amino acid side chains (tryptophan, tyrosine, phenylalanine, histidine) and disulphide bonds, producing a range of degradation products that may not be detectable by visual inspection alone.

Lyophilised Peptide Storage

The appropriate storage temperature for a lyophilised peptide depends on the expected storage duration and the compound's specific stability profile.

Short-term storage (up to 3 months): 2–8°C in a standard laboratory refrigerator is sufficient for most peptides in sealed, intact vials. This is the standard shipping and interim storage condition.

Long-term storage (beyond 3 months): −20°C is recommended for the majority of research peptides. This significantly extends stability by further suppressing thermal degradation pathways and residual moisture activity. Some thermolabile compounds — particularly those with multiple disulphide bonds or complex tertiary structures — may require −80°C for long-term preservation.

Moisture protection: Store peptide vials in a desiccant-containing environment wherever possible, particularly for compounds stored at −20°C where repeated removal from and return to the freezer creates thermal cycling that can drive condensation. Sealed vials stored in a desiccant box or with silica gel sachets are substantially better protected than vials stored unsealed or without desiccant. Storing under inert gas (nitrogen or argon) provides additional protection against oxidative degradation for particularly sensitive compounds.

Vial integrity: Keep vials sealed until the point of reconstitution. The sealed vial with its intact rubber septum and crimped aluminium cap maintains the internal nitrogen atmosphere established during lyophilisation. Once the septum is punctured for reconstitution, the protective atmosphere is compromised and the drying cycle is effectively terminated — the reconstituted solution should be treated accordingly.

Reconstituted Peptide Storage

Once reconstituted, the peptide is in aqueous solution and subject to all the solution-phase degradation mechanisms that lyophilisation was designed to prevent.

Standard storage: Reconstituted peptide solutions should be stored at 2–8°C and used within 28 days when reconstituted with bacteriostatic water. This 28-day window is grounded in USP <797> guidance on multi-dose preparations with benzyl alcohol preservative.

Do not freeze the reconstituted solution: This is a critical point that is frequently misunderstood. Freezing a reconstituted peptide solution causes the formation of ice crystals within the solution matrix. Ice crystal growth physically disrupts the hydrogen bonding networks that maintain peptide conformation and can cause aggregation, precipitation, and irreversible structural changes in the peptide — particularly for larger, structurally complex peptides. Upon thawing, precipitate may be visible, or aggregation may have occurred without visible signs, silently altering the effective concentration and activity profile of the preparation.

Exception — freeze-thaw aliquots: If a research protocol requires frozen storage of portions of the reconstituted peptide for later use, individual single-use aliquots may be prepared using sterile water (not bacteriostatic water) and stored at −20°C. Each aliquot should be used immediately after thawing and not re-frozen. Sterile water is used in this case because the benzyl alcohol preservative in bacteriostatic water has been shown to cause haemolysis at some concentrations and its presence may confound certain assay systems. Single-use, sterile-water aliquots should be used within 24 hours of thawing.

Light Sensitivity

Light-induced degradation is an underappreciated source of peptide instability in laboratory settings. Standard fluorescent and LED laboratory lighting emits a spectrum that includes wavelengths capable of driving photo-oxidation of aromatic amino acid residues.

Storage: All peptide vials should be stored in opaque packaging, amber glass vials, or a dark cabinet. Do not store peptides in clear glass vials under direct light.

Handling: Minimise exposure to laboratory lighting during reconstitution and sample preparation. For particularly light-sensitive compounds, working under low-light conditions or covering vials with aluminium foil during reconstitution is appropriate.

GHK-Cu specifics: GHK-Cu is particularly light-sensitive due to the copper(II) complex, which participates in light-driven redox reactions. The slight blue colour of the reconstituted solution is normal; intensification of colour or precipitation after light exposure is a degradation indicator. Store GHK-Cu vials and reconstituted solutions in light-protective conditions at all times.

Novahelix ships all peptides in light-protective packaging as standard.

Temperature Excursions During Transit

Brief temperature excursions during shipping are a practical reality that researchers should understand in order to assess the impact on their compounds upon receipt.

Lyophilised peptides: A brief excursion of up to 2 hours at room temperature (up to approximately 25°C) during transit is generally acceptable for lyophilised peptides in sealed vials, provided the compound is returned to appropriate storage conditions promptly upon receipt. The lyophilised form is substantially more robust to short thermal excursions than the reconstituted solution.

Reconstituted peptides: Reconstituted solutions should not exceed 25°C for any significant period during handling. Extended excursions above this temperature should be treated as potentially compromising to compound integrity.

Documentation: Any temperature excursion that is prolonged or severe should be documented in the research record. For critical experiments, researchers may wish to perform stability testing on the affected batch before proceeding with primary data collection.

Novahelix Cold Chain Shipping

Novahelix uses temperature-controlled insulated packaging with gel ice packs for all orders. Peptides are typically shipped at 2–8°C, with insulation and ice pack configurations selected to maintain this temperature range for 24–48 hours in transit under Australian conditions. Tracking and transit time estimates are provided with each order to assist researchers in planning receipt and immediate storage. Upon receipt, all vials should be immediately transferred to the appropriate storage condition (refrigerator or freezer, as indicated per compound on the COA).

Handling Best Practices

• Personal protective equipment: Wear nitrile gloves and a laboratory coat when handling peptide vials and reconstituted solutions. The primary purpose in this context is to prevent contamination of the research compound with skin oils, proteases from skin surface bacteria, or other contaminants from the researcher's hands — not personal protection from the compound itself.
• Minimise vial opening time: When withdrawing reconstituted solution, insert the needle, withdraw the required volume, and re-cap the vial promptly. Minimising the duration of septum exposure to the laboratory environment reduces contamination risk.
• Equipment temperature: For temperature-sensitive reconstitutions, pre-chill syringes and work surfaces to 4°C before use.
• Compound-specific guidance: The Novahelix COA for each batch includes storage condition recommendations based on the supplier's compound-specific stability data. These recommendations take precedence over the general guidance provided here where they differ. Refer to the COA for each compound before establishing storage protocols.